HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
-6.86%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$166M
AUM Growth
+$166M
(+5.3%)
Cap. Flow
+$25.5M
Cap. Flow
% of AUM
15.39%
Top 10 Holdings %
Top 10 Hldgs %
40.91%
Holding
125
New
39
Increased
43
Reduced
18
Closed
15
Top Buys
| 1 |
Mastercard
MA
|
$4.04M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
$3.45M |
| 3 |
TEGNA Inc
TGNA
|
$3.02M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
$2.39M |
| 5 |
BCYC
Bicycle Therapeutics
BCYC
|
$2.23M |
Top Sells
| 1 |
PBCT
People's United Financial Inc
PBCT
|
$3.92M |
| 2 |
Fidelity National Information Services
FIS
|
$3.85M |
| 3 |
CERN
Cerner Corp
CERN
|
$3.49M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$1.5M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$979K |
Sector Composition
| 1 | Healthcare | 46.47% |
| 2 | Technology | 22.39% |
| 3 | Financials | 16.85% |
| 4 | Communication Services | 4.29% |
| 5 | Consumer Discretionary | 2.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Iovance Biotherapeutics
IOVA
$807M
| $496K | 0.3% | 44,962 -9,439 | -17% | -$104K |
|
|
SWTX
77
DELISTED
SpringWorks Therapeutics
SWTX
| $470K | 0.28% | 19,080 +11,325 | +146% | +$279K |
|
78
Keros Therapeutics
KROS
$618M
| $459K | 0.28% | 16,623 +583 | +4% | +$16.1K |
|
79
PTC
PTC
$25.6B
| $458K | 0.28% | +4,310 | New | +$458K |
|
80
Regenxbio
RGNX
$451M
| $404K | 0.24% | +16,352 | New | +$404K |
|
81
Revolution Medicines
RVMD
$7.1B
| $403K | 0.24% | +20,685 | New | +$403K |
|
82
iTeos Therapeutics
ITOS
| $390K | 0.24% | 18,913 -3,899 | -17% | -$80.4K |
|
83
Neurocrine Biosciences
NBIX
$13.8B
| $367K | 0.22% | +3,767 | New | +$367K |
|
84
Protagonist Therapeutics
PTGX
$3.67B
| $367K | 0.22% | 46,459 -45,586 | -50% | -$360K |
|
85
Avidity Biosciences
RNA
$5.99B
| $361K | 0.22% | 24,864 -28,300 | -53% | -$411K |
|
86
ServiceNow
NOW
$190B
| $348K | 0.21% | +732 | New | +$348K |
|
87
T-Mobile US
TMUS
$284B
| $348K | 0.21% | +2,588 | New | +$348K |
|
88
Madrigal Pharmaceuticals
MDGL
$9.76B
| $344K | 0.21% | 4,800 +275 | +6% | +$19.7K |
|
|
BLU
89
DELISTED
BELLUS Health Inc.
BLU
| $336K | 0.2% | 36,364 -28,810 | -44% | -$266K |
|
90
PMV Pharmaceuticals
PMVP
$74.2M
| $332K | 0.2% | +23,324 | New | +$332K |
|
91
Bilibili
BILI
$9.6B
| $327K | 0.2% | +12,770 | New | +$327K |
|
92
JD.com
JD
$44.1B
| $327K | 0.2% | +5,098 | New | +$327K |
|
|
RXDX
93
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $304K | 0.18% | +10,782 | New | +$304K |
|
94
Autodesk
ADSK
$67.3B
| $303K | 0.18% | +1,766 | New | +$303K |
|
|
IMAB
95
I-MAB
IMAB
$340M
| $300K | 0.18% | 26,534 +1,132 | +4% | +$12.8K |
|
|
AVTA
96
DELISTED
Avantax, Inc. Common Stock
AVTA
| $293K | 0.18% | +15,872 | New | +$293K |
|
97
Willis Towers Watson
WTW
$31.9B
| $291K | 0.18% | +1,474 | New | +$291K |
|
98
Autoliv
ALV
$9.53B
| $281K | 0.17% | +3,914 | New | +$281K |
|
99
Salesforce
CRM
$245B
| $277K | 0.17% | +1,676 | New | +$277K |
|
100
Expedia Group
EXPE
$26.6B
| $246K | 0.15% | +2,592 | New | +$246K |
|